Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biodesix (BDSX) Total Non-Current Liabilities (2019 - 2025)

Biodesix's Total Non-Current Liabilities history spans 7 years, with the latest figure at $72.5 million for Q4 2025.

  • For Q4 2025, Total Non-Current Liabilities rose 16.85% year-over-year to $72.5 million; the TTM value through Dec 2025 reached $72.5 million, up 16.85%, while the annual FY2025 figure was $72.5 million, 16.85% up from the prior year.
  • Total Non-Current Liabilities reached $72.5 million in Q4 2025 per BDSX's latest filing, roughly flat from $72.3 million in the prior quarter.
  • In the past five years, Total Non-Current Liabilities ranged from a high of $72.5 million in Q4 2025 to a low of $24.1 million in Q1 2022.
  • Average Total Non-Current Liabilities over 5 years is $54.3 million, with a median of $58.9 million recorded in 2023.
  • Peak YoY movement for Total Non-Current Liabilities: plummeted 61.77% in 2022, then surged 125.05% in 2023.
  • A 5-year view of Total Non-Current Liabilities shows it stood at $27.4 million in 2021, then skyrocketed by 80.45% to $49.5 million in 2022, then increased by 23.53% to $61.1 million in 2023, then increased by 1.56% to $62.1 million in 2024, then increased by 16.85% to $72.5 million in 2025.
  • Per Business Quant, the three most recent readings for BDSX's Total Non-Current Liabilities are $72.5 million (Q4 2025), $72.3 million (Q3 2025), and $71.4 million (Q2 2025).